NDC 62756-970
Buprenorphine and Naloxone 2 mg / 8 mg tablet
On the label: Caraco Pharmaceutical Laboratories, Ltd..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | Dadra, India | Makes it and tests it | Problems found, fixed voluntarilyMar 29, 2019 · 5 inspections |
Recalls
- Oct 18, 2022 · Class II · Sun Pharmaceutical Industries Inc
Presence of Foreign Substance
Lots: Lot #: DNC1129A, Exp 06/2023 Lot #: DNC1740A, Exp 09/2023
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Buprenorphine and Naloxone: every company that makes it
- Form
- tablet, sublingual
- Strength
- 2 mg / 8 mg
- Approval
- ANDA ANDA201633
- On the market since
- Jul 18, 2017
- Package NDCs
62756-970-6462756-970-83- Official label
- DailyMed (National Library of Medicine), updated Feb 10, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?